Home > Qtrly Results > ORCHID PHARMA

ORCHID PHARMA
Quarterly Results Analysis [Dec2024]

COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
Audited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Revenues ₹217 Cr ₹223 Cr ₹244 Cr ₹217 Cr ₹221 Cr ₹199 Cr ₹183 Cr ₹210 Cr
Expenses ₹191 Cr ₹192 Cr ₹212 Cr ₹188 Cr ₹185 Cr ₹175 Cr ₹161 Cr ₹170 Cr
Operating Income ₹26 Cr ₹30 Cr ₹32 Cr ₹29 Cr ₹35 Cr ₹23 Cr ₹22 Cr ₹40 Cr
Other Income ₹8 Cr ₹8 Cr ₹8 Cr ₹13 Cr ₹8 Cr ₹8 Cr ₹2 Cr ₹2 Cr
Interest ₹4 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹6 Cr ₹7 Cr
Depreciation ₹9 Cr ₹9 Cr ₹8 Cr ₹8 Cr ₹9 Cr ₹8 Cr ₹8 Cr ₹7 Cr
Profit Before Tax ₹22 Cr ₹26 Cr ₹28 Cr ₹30 Cr ₹30 Cr ₹20 Cr ₹11 Cr ₹66 Cr
Profit After Tax ₹22 Cr ₹26 Cr ₹28 Cr ₹34 Cr ₹30 Cr ₹20 Cr ₹11 Cr ₹66 Cr
EPS ₹4.10 ₹5.37 ₹5.79 ₹6.50 ₹5.80 ₹3.90 ₹1.85 ₹14.49
Industry Peers & Returns1W1M1Y
ORCHID PHARMA 2.4% -13.4% -28.3%
SUN PHARMACEUTICAL INDUSTRIES 2.3% 11.7% 5.1%
DIVIS LABORATORIES -1.6% 4% 58.7%
CIPLA 0.8% 6.2% -2.9%
TORRENT PHARMACEUTICALS 0.7% 9.8% 19.8%
DR REDDYS LABORATORIES -1% 2.8% -8%
MANKIND PHARMA -1.4% 4.5% 4.7%
ZYDUS LIFESCIENCES 1.1% 3.5% -10.8%
LUPIN 3.7% 7.3% 23.8%

ORCHID PHARMA Quarterly Revenues

Revenues
Q-o-Q

-2.41 %

Y-o-Y

-1.47 %

Quarters Revenues % Change
Dec2024 ₹217 Cr
-2.41
Sep2024 ₹223 Cr
-8.88
Jun2024 ₹244 Cr
12.58
Mar2024 ₹217 Cr
-1.58
Dec2023 ₹221 Cr
10.99
Sep2023 ₹199 Cr
8.66
Jun2023 ₹183 Cr
-12.85
Mar2023 ₹210 Cr -

ORCHID PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-13.10 %

Y-o-Y

-25.50 %

Quarters Operating Profit % Change
Dec2024 ₹26 Cr
-13.10
Sep2024 ₹30 Cr
-6.63
Jun2024 ₹32 Cr
12.36
Mar2024 ₹29 Cr
-18.29
Dec2023 ₹35 Cr
51.79
Sep2023 ₹23 Cr
5.29
Jun2023 ₹22 Cr
-44.21
Mar2023 ₹40 Cr -
Operating Margins
Q-o-Q

-10.94 %

Y-o-Y

-24.38 %

Quarters Operating Margin% % Change
Dec2024 12.13%
-10.94
Sep2024 13.62%
2.48
Jun2024 13.29%
-0.23
Mar2024 13.32%
-16.96
Dec2023 16.04%
36.74
Sep2023 11.73%
-3.06
Jun2023 12.1%
-36.01
Mar2023 18.91% -

ORCHID PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-13.32 %

Y-o-Y

-25.64 %

Quarters Profit After Tax % Change
Dec2024 ₹22 Cr
-13.32
Sep2024 ₹26 Cr
-8.40
Jun2024 ₹28 Cr
-15.60
Mar2024 ₹34 Cr
10.96
Dec2023 ₹30 Cr
50.78
Sep2023 ₹20 Cr
85.84
Jun2023 ₹11 Cr
-83.66
Mar2023 ₹66 Cr -
PAT Margins
Q-o-Q

-11.18 %

Y-o-Y

-24.54 %

Quarters PAT Margin(%) % Change
Dec2024 10.33 %
-11.18
Sep2024 11.63 %
0.52
Jun2024 11.57 %
-25.02
Mar2024 15.43 %
12.71
Dec2023 13.69 %
35.95
Sep2023 10.07 %
70.97
Jun2023 5.89 %
-81.25
Mar2023 31.41 % -

ORCHID PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-23.65 %

Y-o-Y

-29.31 %

Quarters EPS % Change
Dec2024 ₹4.1
-23.65
Sep2024 ₹5.37
-7.25
Jun2024 ₹5.79
-10.92
Mar2024 ₹6.5
12.07
Dec2023 ₹5.8
48.72
Sep2023 ₹3.9
110.81
Jun2023 ₹1.85
-87.23
Mar2023 ₹14.49 -

You may also like the below Video Courses